FIELD: chemical-pharmaceutical industry. SUBSTANCE: invention relates to an aqueous composition for aerosol nasal administration of desmopressin that is a synthetic analog of vasopressin. The composition has desmopressin at amount from 2.5 to 7.5 mcg/100 mcl. This composition can contain additionally an agent for osmotic pressure control, for example, sodium chloride, preserving agent, for example, chlorobutanol or benzalkonium chloride and a buffer for stabilizing pH values at the range 4-6. Buffers containing citrate and/or phosphate are preferable. Also, invention proposes hermetically closed container filled with indicated composition, device including this container and aerosol pump. Invention relates also to the use of the proposed composition, container and device used for treatment of patients with urine disorders. EFFECT: design of aerosol desmopressin-containing composition, broadened pattern of patients treatment by age. 25 cl, 1 dwg, 3 ex
Title | Year | Author | Number |
---|---|---|---|
ADMINISTRATION OF DESMOPRESSIN BY NASAL ROUTE | 1997 |
|
RU2173559C2 |
AQUEOUS SOLUTION FOR NASAL INJECTION OF BIOLOGICALLY-ACTIVE PEPTIDE, AND SEALED CONTAINER | 1994 |
|
RU2140281C1 |
STABILIZED COMPOSITION FOR ORAL ADMINISTRATION OF PEPTIDES | 1995 |
|
RU2140790C1 |
FAST-DISSOLVING PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2566270C2 |
SAFE APPLICATION OF DESMOPRESSINUM | 2010 |
|
RU2569756C2 |
FAST-DISSOLVING PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2566269C2 |
COMPOSITION CONTAINING DESMOPRESSIN | 2007 |
|
RU2340351C1 |
DESMOPRESSIN-CONTAINING SOLID PHARMACEUTICAL FORMULATION | 2004 |
|
RU2290945C2 |
DESMOPRESSIN MEDICINAL FORMULATION DISPERSED IN MOUTH CAVITY | 2003 |
|
RU2292903C2 |
DESMOPRESSIN PHARMACEUTICAL COMPOSITION AS SOLID DOSED MEDICINAL FORMULATION AND METHOD FOR ITS PREPARING | 2004 |
|
RU2303439C2 |
Authors
Dates
1999-08-27—Published
1994-06-22—Filed